The global contraceptives market, based on hormones or spermicides, depicts varied financial dynamics by country. With Germany leading at $26.35 billion, other significant markets include Argentina with a 3.2% growth. Italy and Spain experienced declines, registering at -9.17% and -7.16% respectively, while emerging markets like New Zealand and Moldova show growth. Notably, France experienced a contraction at -36.31%, marking a significant downturn.
Looking ahead, key trends involve the diversification of contraceptive types, increasing accessibility in emerging markets, and innovation-driven demand. Policy changes and health awareness may also play crucial roles in shaping future market dynamics.
Top countries in Contraceptives (Based on Hormones or Spermicides) Market Size Value Share by Country (US Dollars)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 26.35 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 20.08 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 13.22 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 11.66 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 6.71 | 2023 | -0.61% | -1.89% | View data |
| 6 | 6 Thailand | 4.03 | 2023 | -0.41% | +0.22% | View data |
| 7 | 7 Poland | 3.59 | 2023 | -6.03% | -4.93% | View data |
| 8 | 8 Switzerland | 3.39 | 2023 | -5.57% | -3.62% | View data |
| 9 | 9 Ukraine | 2.34 | 2023 | -0.81% | -0.71% | View data |
| 10 | 10 New Zealand | 1.53 | 2023 | +2.59% | +3.2% | View data |
